Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujit Basu

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|June 15, 2026
Beyond inhibition: harnessing the DRD2-VEGF-A feedback loop for precision anti-angiogenesis therapy in cancerManas Ranjan Sahu, Venu Akkanapally, Partha Sarathi Dasgupta, et al.
Cancer Research|April 23, 2009
Catecholamines regulate tumor angiogenesisDebanjan Chakroborty, Chandrani Sarkar, Biswarup Basu, et al.
Brain, Behavior, and Immunity|November 10, 2009
The immunoregulatory role of dopamine: an updateChandrani Sarkar, Biswarup Basu, Debanjan Chakroborty, et al.
Molecular Carcinogenesis|January 22, 2021
Suppression of beta 2 adrenergic receptor actions prevent UVB mediated cutaneous squamous cell tumorigenesis through inhibition of VEGF-A induced angiogenesisKai Lu, Madhavi Bhat, Sara Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical modelsChandrani Sarkar, Debanjan Chakroborty, Uttio Roy Chowdhury, et al.
Journal of Cell Science|May 20, 2022
VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cellsChandrani Sarkar, Debanjan Chakroborty, Sandeep Goswami, et al.
The American Journal of Pathology|July 17, 2016
Activation of Dopamine D1 Receptors in Dermal Fibroblasts Restores Vascular Endothelial Growth Factor-A Production by These Cells and Subsequent Angiogenesis in Diabetic Cutaneous Wound TissuesDebanjan Chakroborty, Chandrani Sarkar, Kai Lu, et al.
British Journal of Cancer|July 28, 2022
Neuropeptide Y, a paracrine factor secreted by cancer cells, is an independent regulator of angiogenesis in colon cancerDebanjan Chakroborty, Sandeep Goswami, Hao Fan, et al.
Journal of Nanobiotechnology|November 1, 2006
Inorganic phosphate nanorods are a novel fluorescent label in cell biologyChitta Ranjan Patra, Resham Bhattacharya, Sujata Patra, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 17, 2004
Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cellsChandrani Sarkar, Debanjan Chakroborty, Rita Basu Mitra, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|June 15, 2026
Beyond inhibition: harnessing the DRD2-VEGF-A feedback loop for precision anti-angiogenesis therapy in cancerManas Ranjan Sahu, Venu Akkanapally, Partha Sarathi Dasgupta, et al.
Cancer Research|April 23, 2009
Catecholamines regulate tumor angiogenesisDebanjan Chakroborty, Chandrani Sarkar, Biswarup Basu, et al.
Brain, Behavior, and Immunity|November 10, 2009
The immunoregulatory role of dopamine: an updateChandrani Sarkar, Biswarup Basu, Debanjan Chakroborty, et al.
Molecular Carcinogenesis|January 22, 2021
Suppression of beta 2 adrenergic receptor actions prevent UVB mediated cutaneous squamous cell tumorigenesis through inhibition of VEGF-A induced angiogenesisKai Lu, Madhavi Bhat, Sara Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical modelsChandrani Sarkar, Debanjan Chakroborty, Uttio Roy Chowdhury, et al.
Journal of Cell Science|May 20, 2022
VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cellsChandrani Sarkar, Debanjan Chakroborty, Sandeep Goswami, et al.
The American Journal of Pathology|July 17, 2016
Activation of Dopamine D1 Receptors in Dermal Fibroblasts Restores Vascular Endothelial Growth Factor-A Production by These Cells and Subsequent Angiogenesis in Diabetic Cutaneous Wound TissuesDebanjan Chakroborty, Chandrani Sarkar, Kai Lu, et al.
British Journal of Cancer|July 28, 2022
Neuropeptide Y, a paracrine factor secreted by cancer cells, is an independent regulator of angiogenesis in colon cancerDebanjan Chakroborty, Sandeep Goswami, Hao Fan, et al.
Journal of Nanobiotechnology|November 1, 2006
Inorganic phosphate nanorods are a novel fluorescent label in cell biologyChitta Ranjan Patra, Resham Bhattacharya, Sujata Patra, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 17, 2004
Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cellsChandrani Sarkar, Debanjan Chakroborty, Rita Basu Mitra, et al.
Pageof 5